T

Tandem Diabetes Care
D

TNDM

12.820
USD
0.42
(3.39%)
مفتوح الان
حجم التداول
3,569
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
862,186,450
أصول ذات صلة
ABT
ABT
0.705
(0.53%)
132.940 USD
BSX
BSX
-0.100
(-0.09%)
107.210 USD
DXCM
DXCM
0.110
(0.14%)
80.880 USD
EW
EW
-0.065
(-0.08%)
80.900 USD
ISRG
ISRG
8.77
(1.93%)
466.95 USD
MDT
MDT
0.910
(0.98%)
92.890 USD
PODD
PODD
1.75
(0.51%)
348.20 USD
SYK
SYK
0.00
(0.00%)
392.22 USD
TMO
TMO
3.14
(0.64%)
492.59 USD
ZBH
ZBH
0.945
(0.90%)
105.695 USD
المزيد
الأخبار المقالات

العنوان: Tandem Diabetes Care

القطاع: Healthcare
الصناعة: Medical Devices
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.